標(biāo)題: Titlebook: Nanotherapy for Brain Tumor Drug Delivery; Vivek Agrahari,Anthony Kim,Vibhuti Agrahari Book 2021 Springer Science+Business Media, LLC, par [打印本頁(yè)] 作者: MOTE 時(shí)間: 2025-3-21 18:45
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery影響因子(影響力)
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery影響因子(影響力)學(xué)科排名
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery被引頻次
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery被引頻次學(xué)科排名
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery年度引用
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery年度引用學(xué)科排名
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery讀者反饋
書(shū)目名稱Nanotherapy for Brain Tumor Drug Delivery讀者反饋學(xué)科排名
作者: irreparable 時(shí)間: 2025-3-21 22:29
Drug Delivery Approaches and Imaging Techniques for Brain Tumor,ention (EPR) effect, cell-penetrating peptides (CPP), ligand-mediated delivery, etc. have been discussed briefly to overcome the BBB and its advantages and limitations including other delivery system such as vaccines, stem cell therapy, etc. However, the main focus of this book chapter is on nanopar作者: 放縱 時(shí)間: 2025-3-22 02:51
Surface-Modified Nanodrug Carriers for Brain Cancer Treatment,ace molecules, including the fibroblast growth factor-inducible 14 (Fn14) receptor, employed for targeting nanodrug carriers to GBM. Importantly, we review an advanced nanotherapeutic formulation developed by our team designed for optimal (1) brain tumor accumulation and penetration by reducing nons作者: SOBER 時(shí)間: 2025-3-22 06:33
Strategies to Enhance the Distribution of Therapeutic Nanoparticles in the Brain by Convection Enha within healthy and tumor-bearing brains. In this book chapter, we first briefly overview the mechanism and current limitations of CED, as well as strategies to maximize the CED-mediated therapeutic and/or NP delivery to the brain. We then describe a detailed methodology for preclinical CED experime作者: 衰弱的心 時(shí)間: 2025-3-22 12:06 作者: Indicative 時(shí)間: 2025-3-22 14:56 作者: prolate 時(shí)間: 2025-3-22 19:14 作者: seduce 時(shí)間: 2025-3-22 23:12 作者: 尊重 時(shí)間: 2025-3-23 04:52 作者: 假裝是你 時(shí)間: 2025-3-23 07:59 作者: dainty 時(shí)間: 2025-3-23 11:58
Paula Schiapparelli,Montserrat Lara-Velazquez,Rawan Al-kharboosh,Hao Su,Honggang Cui,Alfredo Quinone作者: 脆弱帶來(lái) 時(shí)間: 2025-3-23 17:49 作者: Afflict 時(shí)間: 2025-3-23 18:31 作者: 上漲 時(shí)間: 2025-3-24 00:29
Pavlos Anastasiadis,Jeffrey A. Winkles,Anthony J. Kim,Graeme F. Woodworth作者: intuition 時(shí)間: 2025-3-24 02:26
Yen Nguyen,Sandeep Kaur,Hae Shim,Vaibhav Mundra,Venkatareddy Nadithe作者: Inflammation 時(shí)間: 2025-3-24 10:32
Jo?o Basso,José Sereno,Ana Fortuna,Miguel Castelo-Branco,Carla Vitorino作者: Promotion 時(shí)間: 2025-3-24 12:25
Book 2021ok cover diverse topics and techniques in nanoparticle drug delivery, gene therapy, neurosurgical brain implant, exosomes, MRI-guided focused ultrasound (MRgFUS), and advanced preclinical glioblastoma multiforme animal models. Some chapters discuss state-of-the-art and innovative nanomedicines for g作者: Pericarditis 時(shí)間: 2025-3-24 16:52
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicineble applications in advancing or ameliorating GBM management. In this chapter, we will therefore analyze the state of the art and the most novel and outstanding innovation in terms of diagnosis and treatment options.作者: 婚姻生活 時(shí)間: 2025-3-24 20:23 作者: 無(wú)法破譯 時(shí)間: 2025-3-25 00:05
Liposome-Templated Hydrogel Nanoparticles for Targeted Delivery of CRISPR/Cas9 to Brain Tumors,ock out GFP expression in U87MG-GFP brain tumor-bearing mice. Thus, LHNPs are capable of not only highly efficient gene editing but also penetrating the blood-brain barrier for gene therapy in the brain. Overall, LHNPs have the potential to serve as a powerful CRISPR/Cas9 delivery vehicle for clinical applications.作者: Macronutrients 時(shí)間: 2025-3-25 04:25
Methods to Separate, Characterize, and Encapsulate Drug Molecules into Exosomes for Targeted Deliven, rhodamine) or large protein-based molecules (catalase) or nucleic acid-based drugs such as small interfering RNA (siRNA). In this chapter, we will focus on describing exosome isolation, characterization, and drug loading methods that are suitable for studying and treating glioblastoma.作者: jettison 時(shí)間: 2025-3-25 10:11 作者: Collar 時(shí)間: 2025-3-25 14:31
Strategies to Modulate the Blood-Brain Barrier for Directed Brain Tumor Targeting,les is to get newly discovered therapeutic agents across the blood-brain barrier (BBB) to penetrate the brain parenchyma. In this context, this book chapter provides an overview of three different strategies of delivering antitumor agents intended to circumvent the BBB and highlight the strengths and weakness of each approach.作者: 大看臺(tái) 時(shí)間: 2025-3-25 17:21
Establishing Orthotopic Xenograft Glioblastoma Models for Use in Preclinical Development,e frontline of neuro-oncology as an experimental system to identify novel therapeutic targets and to determine the efficacy of different therapeutic agents and/or nanosystems. The present chapter describes a protocol for establishing brain tumor xenografts in mice following a single injection of glioblastoma cells.作者: 內(nèi)部 時(shí)間: 2025-3-25 22:49
Neuromethodshttp://image.papertrans.cn/n/image/661150.jpg作者: floaters 時(shí)間: 2025-3-26 03:23
https://doi.org/10.1007/978-1-0716-1052-7brain cancer; malignant gliomas; Nano-biotechnology; stem cell; molecular imaging作者: 大包裹 時(shí)間: 2025-3-26 07:14 作者: 溫和女孩 時(shí)間: 2025-3-26 08:50 作者: 兵團(tuán) 時(shí)間: 2025-3-26 15:14
Vivek Agrahari,Anthony Kim,Vibhuti AgrahariIncludes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts作者: 松軟無(wú)力 時(shí)間: 2025-3-26 19:45
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicinecovered in late stages and is normally deadly, having a life expectancy of 12–15?months and a mere 3% of the affected patients living 3?years or more independent of race, sex, and age. Sadly, current treatments (i.e., chemotherapy, radiation, surgery) are extremely aggressive and extend the patient’作者: 緊張過(guò)度 時(shí)間: 2025-3-27 00:31 作者: Implicit 時(shí)間: 2025-3-27 03:32
Strategies to Modulate the Blood-Brain Barrier for Directed Brain Tumor Targeting,erized tumors, patient prognosis remains dismal. Many factors have contributed to the challenges of developing effective clinical therapies, such as tumor heterogeneity, immune-suppressive microenvironment, and therapy resistance. From the perspective of therapeutics delivery, one of the main obstac作者: Scintillations 時(shí)間: 2025-3-27 06:30 作者: entitle 時(shí)間: 2025-3-27 13:31 作者: 邊緣帶來(lái)墨水 時(shí)間: 2025-3-27 16:11 作者: left-ventricle 時(shí)間: 2025-3-27 20:03
Strategies to Enhance the Distribution of Therapeutic Nanoparticles in the Brain by Convection Enhaitate widespread therapeutic distribution within brain parenchyma by creating a continuous pressure-driven bulk flow. However, rapid removal of therapeutics from the brain by the physiological clearance mechanism remains a critical challenge to achieving widespread therapeutic delivery by CED. Nanop作者: thwart 時(shí)間: 2025-3-28 00:34 作者: 無(wú)所不知 時(shí)間: 2025-3-28 04:33
Neurosurgical Implant-Based Strategy for Brain Cancer Therapy,selective blood-brain barrier. For many years biodegradable polymers were investigated as potential drug delivery systems. However, polymer technology in the drug delivery setting only truly advanced after the polyanhydrides were tested and demonstrated to be safe and effective platforms for control作者: 噴出 時(shí)間: 2025-3-28 07:24
Liposome-Templated Hydrogel Nanoparticles for Targeted Delivery of CRISPR/Cas9 to Brain Tumors,larly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) has the potential to significantly advance cancer gene therapy. However, clinical translation of CRISPR/Cas9 for brain cancer treatment requires the development of approaches able to simultaneously overcome cellu作者: Foam-Cells 時(shí)間: 2025-3-28 13:27
Methods to Separate, Characterize, and Encapsulate Drug Molecules into Exosomes for Targeted Delivelenges posed by BBB. However, drug delivery to the brain is still a hurdle that has yet to be solved. Due to the tight junctions and high selectivity of the BBB, most active and passive strategies deliver an insufficient or insignificant amount of drug across the protective BBB shield. Recently, exo作者: Irksome 時(shí)間: 2025-3-28 16:48 作者: CLOT 時(shí)間: 2025-3-28 19:24 作者: insurgent 時(shí)間: 2025-3-29 00:28
8樓作者: 轉(zhuǎn)折點(diǎn) 時(shí)間: 2025-3-29 06:23
9樓作者: 高興一回 時(shí)間: 2025-3-29 08:10
9樓作者: 招人嫉妒 時(shí)間: 2025-3-29 12:53
9樓作者: 摸索 時(shí)間: 2025-3-29 17:56
9樓作者: Ischemic-Stroke 時(shí)間: 2025-3-29 23:38
10樓作者: vasospasm 時(shí)間: 2025-3-30 03:13
10樓作者: 來(lái)這真柔軟 時(shí)間: 2025-3-30 04:12
10樓作者: 地牢 時(shí)間: 2025-3-30 11:52
10樓
